Parasite polyamine synthesis and utilization pathway

The parasite polyamine synthesis and utilization pathway is a critical metabolic network responsible for the production and maintenance of polyamines such as putrescine, spermidine, and spermine [1]. These small, positively charged molecules are indispensable for various cellular processes, including DNA replication, RNA transcription, protein synthesis, and membrane stabilization [2]. In many parasitic protozoa, such as Trypanosoma and Leishmania, polyamines also serve as essential precursors for the synthesis of trypanothione, a unique antioxidant molecule required for maintaining redox homeostasis and protecting the parasite from oxidative stress [1, 3]. Because parasites often exhibit a higher rate of proliferation and a greater dependency on de novo polyamine synthesis compared to host cells, this pathway has become a significant focus for antiparasitic drug development [2, 4]. Drugs like eflornithine (DFMO) exploit differences in enzyme turnover and metabolic requirements to selectively inhibit parasite growth, particularly in the treatment of African Sleeping Sickness [1]. However, the high degree of conservation between parasite and human polyamine enzymes presents challenges in achieving high selectivity and minimizing host toxicity [4].

Other names

Polyamine biosynthetic pathwayPolyamine metabolismProtozoal polyamine pathway

The mechanism involves the depletion of essential intracellular polyamine pools (putrescine, spermidine, and spermine) through the inhibition of rate-limiting enzymes like ornithine decarboxylase (ODC) and S-adenosylmethionine decarboxylase (AdoMetDC), which leads to the cessation of DNA synthesis and cell growth [1, 2]. In certain parasites, this also results in the depletion of trypanothione, thereby increasing susceptibility to oxidative stress [3].